Document Detail


Developments in heart failure 2011.
MedLine Citation:
PMID:  22432558     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Last year, the authors reviewed all studies in the field of heart failure (HF) published in the year 2010. Another year of exciting new developments has gone by and several important papers have been published. Summarized are the important studies published in the year 2011 that may be a useful review for cardiologists and other health care professionals who care for patients with HF.
Authors:
Krishna K Gaddam; Hector Ventura
Related Documents :
22721978 - First, do no harm: less training ≠ quality care.
22751758 - Effect of clinical decision-support systems: a systematic review.
22444098 - Medical management and prevention of nephrolithiasis.
1308008 - Care management for children who are medically fragile/technology-dependent.
564328 - Dyslexia revisited. a review.
15120768 - Evaluation of a short-term group intervention for informal carers of patients attending...
Publication Detail:
Type:  Journal Article; Review     Date:  2012-03-15
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  18     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2012 Mar-Apr
Date Detail:
Created Date:  2012-03-21     Completed Date:  2012-07-31     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  112-26     Citation Subset:  IM    
Copyright Information:
© 2012 Wiley Periodicals, Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers
Defibrillators, Implantable
Heart Failure / drug therapy*,  pathology,  ultrasonography
Heart-Assist Devices
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use*
Prognosis
Renin-Angiotensin System / drug effects
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
Spironolactone / analogs & derivatives*,  therapeutic use
Stroke Volume
Ventricular Function, Left
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Mineralocorticoid Receptor Antagonists; 0/Sodium Potassium Chloride Symporter Inhibitors; 27O7W4T232/Spironolactone; 6995V82D0B/eplerenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Depression and quality of life among heart failure patients in georgia, eastern europe.
Next Document:  Organ-specific responses to circulatory disturbances in heart failure: new insights.